Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Björn Dahlöf , Richard B. Devereux , Sverre E. Kjeldsen +12 more 2002 The Lancet 5386 citations